| Literature DB >> 30359241 |
Justina Kacerauskiene1, Meile Minkauskiene2, Tahir Mahmood3, Egle Bartuseviciene2, Dalia R Railaite2, Arnoldas Bartusevicius2, Mindaugas Kliucinskas2, Ruta J Nadisauskiene2, Kastytis Smigelskas2, Kornelija Maciuliene4, Grazina Drasutiene5, Diana Ramasauskaite5.
Abstract
BACKGROUND: To evaluate the role of the TGCS to reduce the caesarean section (CS) rate among nulliparas (Robson groups 1 and 2) and to find out which group of women have reduced the CS rate by using this tool.Entities:
Keywords: Caesarean section; Intervention; Nulliparas; Rate; Robson classification
Mesh:
Year: 2018 PMID: 30359241 PMCID: PMC6202871 DOI: 10.1186/s12884-018-2052-2
Source DB: PubMed Journal: BMC Pregnancy Childbirth ISSN: 1471-2393 Impact factor: 3.007
The 10-group classification system
| No. | Group |
|---|---|
| Group 1 | Nulliparous, single cephalic, 37 weeks, in spontaneous labour |
| Group 2A | Nulliparous, single cephalic, 37 weeks, induced labour |
| Group 2B | Nulliparous, single cephalic, 37 weeks, CS before labour |
| Group 3 | Multiparous (excluding prev. CS), single cephalic, 37 weeks, in spontaneous labour |
| Group 4A | Multiparous (excluding prev. CS), single cephalic, 37 weeks, induced labour |
| Group 4B | Multiparous (excluding prev. CS), single cephalic, 37 weeks, CS before a labour |
| Group 5A | Previous CS, single cephalic, 37 weeks, induced labour |
| Group 5B | Previous CS, single cephalic, 37 weeks, CS before labour |
| Group 5C | Previous CS, single cephalic, 37 weeks, in spontaneous labour |
| Group 6 | All nulliparous breeches |
| Group 7 | All multiparous breeches (including prev. CS) |
| Group 8 | All multiple pregnancies (including prev. CS) |
| Group 9 | All abnormal lies (including prev. CS) |
| Group 10 | All single cephalic, ≤ 36 weeks (including prev. CS) |
Socio-demographic and personal data
| 2012 | 2014 | ||
|---|---|---|---|
| Living area | |||
| urban, n (%) | 3117 (83.2) | 2886 (80.5) | |
| rural, n (%) | 629 (16.8) | 699 (19.5) | |
| Education | |||
| basic, primary and secondary, n (%) | 1749 (46.7) | 1649 (46.0) | |
| higher, n (%) | 1997 (53.3) | 1936 (54.0) | |
| Marital status | |||
| single, n (%) | 1326 (35.4) | 1089 (30.4) | |
| married, n (%) | 2420 (64.6) | 2496 (69.6) | |
| Age | |||
| < 20, n (%) | 1264 (33.7) | 1142 (31.9) | |
| 20–34, n (%) | 2270 (60.6) | 2224 (62.0) | |
| ≥ 35, n (%) | 212 (5.7) | 219 (6.1) | |
| Maternal diseases | 155 (4.1) | 124 (3.5) | |
The CS rate in 2012 and 2014
| Number of CS over total number of women in each group | Relative size of groups, % | CS rate in each group, % | p value | Absolute contribution to the оverall CS rate, % | p value | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2012 | 2014 | 2012 | 2014 | 2012 | 2014 | 2012 | 2014 | |||
| Group 1 | 426/2776 | 340/2698 | 76.6 | 77.0 | 15.3 | 12.6 | 11.7 | 9.7 | ||
| Group 2 | 440/850 | 326/804 | 23.4 | 23.0 | 51.8 | 40.5 | 12.1 | 9.3 | ||
| Group 2A | 236/646 | 220/698 | 17.8 | 19.9 | 36.5 | 31.5 | 6.5 | 6.3 | ||
| Group 2B | 204/204 | 106/106 | 5.6 | 3.0 | 100 | 100 | – | 5.6 | 3.0 | |
| Group 1 and 2 | 866/3626 | 666/3502 | 23.9 | 19.0 | ||||||
Indications for CS among women in group 1
| Indication | Absolute contribution to the CS rate in group 1, %, 2012 | Absolute contribution to the CS rate in group 1, %, 2014 | p value | Absolute contribution to the overall CS rate, %, 2012 | Absolute contribution to the overall CS rate, %, 2014 | p value |
|---|---|---|---|---|---|---|
| FC (without oxytocin) | 22.1 | 15.9 | 2.6 | 1.5 | ||
| Dystocia | 70.4 | 74.1 | 8.3 | 7.2 | ||
| CCD without oxytocin | 11.7 | 10.0 | 1.4 | 1.0 | ||
| CCD with oxytocin | 17.6 | 20.0 | 2.1 | 2.9 | ||
| ICD without oxytocin | 7.5 | 6.2 | 0.9 | 0.6 | ||
| ICD with oxytocin | 22.5 | 27.9 | 2.6 | 2.7 | ||
| FC with oxytocina | 11 | 10.0 | 1.3 | 1.0 | ||
| Others | 7.5 | 10.0 | 0.9 | 1.0 | p = 0.697 | |
| Total | 11.7 | 9.7 |
a“FC with oxytocin” was attributed to “dystocia” because the reason why oxytocin was administered was dystocia
Peculiarities of deliveries when the indication for CS is “dystocia”
| 2012 | 2014 | p value | |
|---|---|---|---|
| Dystocia: CCD with oxytocin | |||
| Cervical dilatation at the moment of oxytocin administration, cm (mean, SD) | 4.69 (2.11) | 5.7 (2.21) | 0.007 |
| Waiting time passed before making the decision to perform a CS because of dystocia, min (mean, SD) | 88.3 (31.55) | 87.8 (38.7) | 0.933 |
| Dystocia: ICD with oxytocin | |||
| Cervical dilatation at the moment of oxytocin administration, cm (mean, SD) | 3.97 (2.16) | 4.1 (2.24) | 0.68 |
| Cervical dilatation at the moment of the decision to perform a CS because of dystocia, cm (mean, SD) | 5.39 (2.53) | 5.38 (2.61) | 0.991 |
| Waiting time passed before the decision to perform CS because of dystocia, min (mean, SD) | 171.3 (125.7) | 217.21 (164.47) | 0.033 |
Indications for operations in women with elective CSs
| Indication | Absolute contribution to the CS rate in group 2B, %, 2012 | Absolute contribution to the CS rate in group 2B, %, 2014 | p value | Absolute contribution to the overall CS rate, %, 2012 | Absolute contribution to the overall CS rate, %, 2014 | p value |
|---|---|---|---|---|---|---|
| Placental and umbilical cord pathology | 9.8 | 10.4 | 0.6 | 0.3 | ||
| Fetus related conditions | 16.2 | 11.3 | p = 0.25 | 0.9 | 0.3 | |
| Maternal diseases | 48.0 | 49.0 | 2.7 | 1.5 | ||
| Suspected fetal macrosomia | 6.9 | 9.4 | 0.4 | 0.3 | ||
| Preeclampsia | 3.4 | 4.7 | 0.2 | 0.1 | ||
| Post-term pregnancy | 16.7 | 15.1 | 0.9 | 0.5 | ||
| Total | 5.6 | 3.0 |
Newborn-related outcomes
| Indicator | 2012 | 2014 | p value |
|---|---|---|---|
| Newborn weight | |||
| < 3000 g, n (%) | 476 (12.7) | 429 (12.0) | |
| 3000–3999 g, n (%) | 2809 (75.0) | 2691 (75.1) | |
| ≥ 4000 g, n (%) | 461 (12.3) | 465 (13.0) | |
| Apgar score after 5 min | |||
| < 7, n (%) | 6 (0.2) | 2 (0.1) | |
| 7–8, n (%) | 141 (3.8) | 188 (5.2) | |
| ≥ 9, n (%) | 3599 (96.1) | 3395 (94.7) | |
| Perinatal mortality | |||
| antepartum deaths, n | 10 | 7 | |
| intrapartum deaths, n | 1 | 0 | |
| not defined, n | – | – | |
| early neonatal deaths, n | 2 | 4 | |
| perinatal mortality | 3.5/1000 | 3.1/1000 | |